BioPharma Credit PLC (BPCR) — Strategic Asset Allocation Index
BioPharma Credit PLC (BPCR) has a Strategic Asset Allocation Index of 98.4% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $1.16 Billion) total $1.16 Billion, measured against net assets of $1.18 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check BioPharma Credit PLC liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
BioPharma Credit PLC Strategic Asset Allocation Index (2017–2024)
This chart shows how BioPharma Credit PLC's Strategic Asset Allocation Index has evolved across 8 annual periods from 2017 to 2024. As of December 2024, the index stands at 98.4%, representing strategic assets of $1.16 Billion against net assets of $1.18 Billion USD. See how financially flexible is BioPharma Credit PLC to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for BioPharma Credit PLC (2017–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for BioPharma Credit PLC from 2017 to 2024, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see BPCR stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 98.4% | $1.16 Billion | $- | $1.16 Billion | $1.18 Billion | ▲ +8.8 pp |
| 2023 | 89.6% | $1.20 Billion | $- | $1.20 Billion | $1.34 Billion | ▼ -1.9 pp |
| 2022 | 91.5% | $1.22 Billion | $- | $1.22 Billion | $1.34 Billion | ▼ -1.4 pp |
| 2021 | 92.8% | $1.27 Billion | $- | $1.27 Billion | $1.36 Billion | ▲ +6.2 pp |
| 2020 | 86.7% | $1.19 Billion | $- | $1.19 Billion | $1.38 Billion | ▲ +7.1 pp |
| 2019 | 79.5% | $1.12 Billion | $- | $1.12 Billion | $1.40 Billion | ▲ +6.5 pp |
| 2018 | 73.0% | $1.01 Billion | $- | $1.01 Billion | $1.38 Billion | ▲ +11.2 pp |
| 2017 | 61.7% | $569.63 Million | $- | $569.63 Million | $922.57 Million | — |